During the past decade, Narodny onkologicky ustav conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 22 clinical trials were completed, i.e. on average, 122.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 11 clinical trials were completed. i.e. 183.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Narodny onkologicky ustav" #1 sponsor was "Pfizer" with 18 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Bayer" with 3 trials sponsored, "Genmab" with 2 trials sponsored and "Ipsen" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Narodny onkologicky ustav" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Narodny onkologicky ustav" are "Early Breast Cancer" (2 trials), "Head and Neck Cancer" (2 trials), "Kidney Neoplasms" (2 trials), "Lymphoma, Non-Hodgkin" (2 trials) and "Neoplasms" (2 trials). Many other conditions were trialed in "Narodny onkologicky ustav" in a lesser frequency.

Most popular intervention types in "Narodny onkologicky ustav" are "Drug" (31 trials), "Biological" (5 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Rituximab" (4 trials), "Cetuximab" (3 trials), "Paclitaxel" (3 trials) and "Axitinib (AG-013736)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Narodny onkologicky ustav" are 30 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Narodny onkologicky ustav". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Narodny onkologicky ustav, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Narodny onkologicky ustav, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Narodny onkologicky ustav has several departments that took part in Clinical trials: "Narodny Onkologicky Ustav; Oddelenie klinickej onkologie A" - 5 trials, "Narodny Onkologicky Ustav; Oddelenie klinickej onkologie E" - 2 trials